Navigation Links
Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/4/2009

acture of conformance batches at our proposed secondary source supplier of pegloticase API. The above increases in expense were partially offset by approximately $3.2 million of lower technology transfer costs from our proposed secondary source supplier of pegloticase API as the majority of the work was performed in the prior year and has now been substantially completed. Additionally, we incurred lower expenses for reservation fees as the prior year period reflects a $2.2 million payment to BTG to reserve manufacturing space in their facility.

Selling, general and administrative expenses for the first nine months of 2009 were $25.4 million, compared with $27.3 million for the same period of 2008, a decrease of $1.9 million, or 7%. The decrease was primarily due to lower legal fees of $3.2 million as the prior year results reflect expenses for Oxandrin-related patent infringement litigation and $2.1 million of lower compensation and benefits, including share-based compensation, due primarily to decreased headcount and share-based awards. Partially offsetting the lower costs are $1.2 million in higher severance expenses, increased pre-launch market research and recruiting expenses of $1.1 million and $1.0 million, respectively, both incurred in preparation for a potential commercial launch of KRYSTEXXA.

Investment income, net for the first nine months of 2009 was $0.3 million, compared with $1.7 million for the same period of 2008, a decrease of $1.4 million, or 84%. The lower investment income was primarily due to decreased dividend and interest income from lower cash, cash equivalent and investment balances and as a result of lower yields earned on those investments.

Other expense, net for the first nine months of 2009 was $24.4 million, compared with $0.5 million for the same period of 2008, an increase of $23.9 million primarily as a result of the non-cash net loss on the mark-to-market valuation adjustment to our warrant l
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... NAMUR , Belgium , July ... MKT: VNRX), a life sciences company focused on developing ... types and other conditions, today announced that it has ... research organization, Global Specimen Solutions, Inc. (GSS), to support ... colorectal cancer tests. Under the agreement, ...
(Date:7/27/2015)... DUBLIN , July 27, 2015 Research ... of the "Intraoperative Imaging Market by Type (Intraoperative ... America, Europe, Asia-Pacific, ROW) - Global Forecast to 2019" ... market is expected to reach a value of $2.1 ... a CAGR of 3.5% during the forecast period. ...
(Date:7/27/2015)... 2015   Iagnosis , the creator of ... online dermatology solutions, announced today its 2015 year-to-date ... has contractual relationships with dermatologists in 30 states, ... Dermatologists and Extenders Since December 2014, the ... of providers delivering care through the platform, which ...
Breaking Medicine Technology:VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2Iagnosis Reports Significant Growth YTD 2015 2
... Jan. 13, 2011 Baylor Health Care System is ... quality of patient care in North Texas through the ... health care system.  It is one of thousands of ... with the U.S. Department of Health and Human Services ...
... 13, 2011 Dendreon Corporation (Nasdaq: DNDN ) ... other conditions, $500 million aggregate principal amount of convertible senior ... registered under the Securities Act of 1933, as amended (the ... of Dendreon,s common stock (the "Common Stock") or a combination ...
Cached Medicine Technology:Baylor Health Care System Registers its Commitment to Achieve Meaningful Use of the Electronic Health Record 2Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 2Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 3Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 4
(Date:7/27/2015)... , ... July 27, 2015 , ... With a new ... with PursuitSAFETY to support its mission of reducing the number of deaths and injuries ... support victims and their families. PursuitSAFETY works with the police to find better ...
(Date:7/27/2015)... , ... July 27, 2015 , ... For a limited ... promotion on Zoom teeth whitening. Summer is a great time to change up a ... reasons, but discolored teeth can really affect your self-esteem. Over time, the enamel coating ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... fullerenes in medical and diagnostics applications is rapidly increasing and is driven by ... cancer treatment, they are increasingly being evaluated for use in bio implants. MWCNTs ...
(Date:7/27/2015)... ... 27, 2015 , ... The Advocator Group, LLC, a nationwide ... Cogswell as the vice president of client services. Mr. Cogswell has over twenty ... role in the growth and transformation of several businesses, including Bob’s Discount Furniture ...
(Date:7/27/2015)... ... 27, 2015 , ... Premier Insurance Advisors, a full service ... charity and awareness event with the Houston chapter of NAMI, the National Alliance ... to bettering the lives of the millions of Americans affected by mental illness. ...
Breaking Medicine News(10 mins):Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 3Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 2Health News:Fullerene Market to Grow at 13% CAGR to 2019 Says a New Research Report at Sandlerresearch.org 3Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 2Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 3Health News:Premier Insurance and the National Alliance of Mental Health Launch Grassroots Charity Effort to Support Houston Residents with Developmental Challenges 2Health News:Premier Insurance and the National Alliance of Mental Health Launch Grassroots Charity Effort to Support Houston Residents with Developmental Challenges 3
... from NIDCR have created an animal model that ... II and dentin dysplasia. Dr. Ashok Kulkarni and ... amounts of TGF-b1 (transforming growth factor beta-1) in ... apparent defects, but at two weeks their teeth ...
... researchers people who sleep for more or less than seven ... over one million adults conducted over a six year time ... hours sleep a night might need modifying. Looking at the ... expectancy, researchers at the University of Texas, and colleagues, find ...
... an exclusively Western problem. Researchers say weight problems ... in developing nations, particularly children. Until recently, famine ... to the health of poor people in developing ... processing and even leisure time in developing countries ...
... kidney cancer in the UK has risen by 68 per cent ... a year. Research in UK says that 5,700 people each year ... lowest in Europe.// The disease accounts for an estimated 95,000 worldwide ... ,According to Dr Nick James, a consultant at the Queen Elizabeth ...
... conduct tests for any Indian doctor having graduated abroad avid ... higher standards amongst doctors, the government has made it compulsory ... today. , The new regulations, ... students who want to enrol in MBBS course abroad will ...
... men tend to die younger than married ones. Psychiatrists ... health by giving them emotional ward.// ,Researchers in ... heart disease and stroke were higher in unmarried men ... in death rates between married and unmarried women. ...
Cached Medicine News:Health News:Heriditary dental disorders 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: